Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
New Strong Sell Stocks for August 18th
10:45am, Wednesday, 18'th Aug 2021
CYTK, GEVO, ISEE, MCFE, and NOMD have been added to the Zacks Rank #5 (Strong Sell) List on August 18, 2021.
Implied Volatility Surging for IVERIC bio (ISEE) Stock Options
09:59am, Wednesday, 18'th Aug 2021
Investors need to pay close attention to IVERIC bio (ISEE) stock based on the movements in the options market lately.
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2021 Results - Earnings Call Transcript
10:17am, Wednesday, 04'th Aug 2021
IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2021 Results - Earnings Call Transcript
Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results
06:30am, Wednesday, 04'th Aug 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced financial and operating results for the quarter ended June 30, 2021 and provided a general business update.
Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule
07:30am, Monday, 26'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced the early completion of patient enrollment of GATHER2, the Company's 2nd pivotal clinical trial of Zimura® (avacincaptad pegol).
Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech
10:14am, Monday, 19'th Jul 2021
Penny Stocks & Small Caps Jump As Biotech Industry Names Kick Into High Gear The post Small-Cap Stocks To Watch After CYTK Sheds Spotlight On Biotech appeared first on Penny Stocks to Buy, Picks, News
Iveric Bio Appoints Christopher Simms as Chief Commercial Officer
07:30am, Monday, 19'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced today the appointment of Christopher Simms to Senior Vice President and Chief Commercial Officer, effective August 2, 2021.
IVERIC bio (ISEE) Enters Overbought Territory
07:45am, Wednesday, 14'th Jul 2021
IVERIC bio (ISEE) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
Iveric Bio Raises $100M Via Equity To Fund Zimura Development In Geographic Atrophy
07:17am, Tuesday, 13'th Jul 2021
Iveric bio Inc (NASDAQ: ISEE) priced its underwritten public offering of 11.6 million shares at $8.60 per share, representing a discount of 4.6% from the last close price of $9.01 on Monday. Underwr
IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock
10:09pm, Monday, 12'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock.
IVERIC bio, Inc. Announces Proposed Offering of Common Stock
04:07pm, Monday, 12'th Jul 2021
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced that it is commencing an underwritten public offering of shares of its common stock.
Do Options Traders Know Something About IVERIC bio (ISEE) Stock We Don't?
10:06am, Monday, 12'th Jul 2021
Investors need to pay close attention to IVERIC bio (ISEE) stock based on the movements in the options market lately.
IVERIC bio Stock Increased 11.87%: Why It Happened
05:09pm, Wednesday, 07'th Jul 2021
The stock price of IVERIC bio Inc (NASDAQ: ISEE) increased by 11.87%. This is why it happened.
ISEE Stock Price Increases Over 30% Pre-Market: Why It Happened
07:21am, Tuesday, 06'th Jul 2021
The stock price of IVERIC bio Inc (NASDAQ: ISEE) increased by over 30% pre-market. This is why it happened.
NEW YORK--(BUSINESS WIRE)--Iveric Bio announced that the Company received written agreement from the US FDA under a Special Protocol Assessment (SPA) for the design of GATHER2.
